Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next steps for the optimization of exon therapy for Duchenne muscular dystrophy
Galina Filonova, Annemieke Aartsma‐Rus
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 133-143
Open Access | Times Cited: 17

Showing 17 citing articles:

The Future of Exon Skipping for Duchenne Muscular Dystrophy
Annemieke Aartsma‐Rus
Human Gene Therapy (2023) Vol. 34, Iss. 9-10, pp. 372-378
Closed Access | Times Cited: 21
Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO
Umme Sabrina Haque, Melissa Kohut, Toshifumi Yokota
Current Research in Toxicology (2024) Vol. 7, pp. 100182-100182
Open Access | Times Cited: 8
Non-viral delivery of nucleic acid for treatment of rare diseases of the muscle
Divya Rao, Munia Ganguli
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 6
Upregulation of utrophin improves the phenotype of Duchenne muscular dystrophy hiPSC-derived CMs
Kalina Andrysiak, Paweł E. Ferdek, Anna Magdalena Sanetra, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102247-102247
Open Access | Times Cited: 4
Therapeutic targeting of RNA for neurological and neuromuscular disease
Jodi L. Bubenik, Marina M. Scotti, Maurice S. Swanson
Genes & Development (2024)
Open Access | Times Cited: 3
An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database
Jamie Leckie, Abdullah Zia, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 11, pp. 1489-1489
Open Access | Times Cited: 2
Tissue distribution of renadirsen sodium, a dystrophin exon-skipping antisense oligonucleotide, in heart and diaphragm after subcutaneous administration to cynomolgus monkeys
Naotoshi Yamamura, Hideo Takakusa, Daigo Asano, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-17
Closed Access | Times Cited: 1
A systematic literature review and meta-analysis of the effectiveness of vitamin D supplementation for patients with Duchenne muscular dystrophy
Jing Guo, Karen Anthony
Neuromuscular Disorders (2023) Vol. 33, Iss. 11, pp. 835-844
Open Access | Times Cited: 2
Imaging and Serum Biomarkers for Cardiomyopathy in Duchenne Muscular Dystrophy
Elizabeth M. McNally, Karisma Chhabria, Dominic E. Fullenkamp
Circulation Heart Failure (2023) Vol. 16, Iss. 8
Closed Access | Times Cited: 1
Mathematical modeling of the progression of Duchenne Muscular Dystrophy in San Diego in an era of allele specific oligonucleotide therapy
Stephen F. Kingsmore, Dominic Baun, Laura Tobin, et al.
Research Square (Research Square) (2024)
Open Access
AAV-Mediated Restoration of Dystrophin-Dp71 in the Brain of Dp71-Null Mice: Molecular, Cellular and Behavioral Outcomes
Ophélie Vacca, Faouzi Zarrouki, Charlotte Izabelle, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 718-718
Open Access
Design and evaluation of antisense sequence length for modified mouse U7 small nuclear RNA to induce efficient pre-messenger RNA splicing modulation in vitro
Takenori Shimo, Otoya Ueda, Satoshi Yamamoto
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305012-e0305012
Open Access
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Ryan Fischer, Pat Furlong, Annie Kennedy, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 4199-4212
Open Access
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA
A Sakai, Gagandeep Singh, Mahsa Khoshbakht, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102331-102331
Open Access
OLIGONUCLEOTIDES TARGETING THE SPLICE ACCEPTOR SITE DOWNSTREAM OF A MICROEXON AS AN INNOVATIVE THERAPY FOR AUTISM
Ainhoa Martínez‐Pizarro, Sara Picó, Lise Lolle Holm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Ryan Fischer, Pat Furlong, Annie Kennedy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Türkiye'de Duchenne/Becker Musküler Distrofisi Kohortunda Distrofin Gen Delesyonları ve Duplikasyonlarının Dağılımı
Fatma Nihal Öztürk, Pelin Özyavuz Çubuk, Tuğba Akın Duman
OSMANGAZİ JOURNAL OF MEDICINE (2023) Vol. 46, Iss. 1, pp. 9-16
Open Access
Page 1

Scroll to top